The main candidates for in vitro gene correction are monogenic diseases, such as β-thalassemia and hemophilia A. β-Thalassemia is a genetic disorder that is caused by mutations in the human hemoglobin beta (HBB) gene. Here, HBB is linked to hemophilia A.